Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

228.47
Delayed Data
As of Sep 03
 -3.71 / -1.60%
Today’s Change
111.41
Today|||52-Week Range
263.81
+59.65%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line159.6M-116.0M-863.7M912.2M
 
 
 
 
 
Depreciation612.6M986.2M1.4B1.7B
 
 
 
 
 
Total Other Cash Flow264.4M359.3M1.4B319.1M
 
 
 
 
 
Funds From Operations813.6M909.9M1.4B3.0B
 
 
 
 
 
Funds From/For Other Operating Expenses137.1M253.3M378.3M668.4M
 
 
 
 
 
Net Cash Flow - Operating Activities676.5M656.6M1.0B2.3B
 
 
 
 
 
 
InvestingIncrease In Investments-81.1M-7.2M0.00-147.9M
 
 
 
 
Decrease In Investments86.6M624.8M17.0M129.1M
 
 
 
 
 
Capital Expenditures-58.5M-107.6M-115.3M-291.6M
 
 
 
 
 
Fixed Asset Disposal0.0092.0M41.1M1.5B
 
 
 
 
Net Assets From Acquisitions -2.5B-3.5B-5.3B-1.1B
 
 
 
 
 
Other Investing - Uses0.00-8.9M0.000.00
 
 
Net Cash Flow Investing-2.8B-3.0B-5.4B-99.7M
 
 
 
 
 
 
FinancingShort Term Borrowings--4.3M-47.7M-9.0M
 
 
 
 
Long Term Borrowings5.3B6.0B8.3B1.6B
 
 
 
 
 
Long Term Debt Reduction-2.6B-1.9B-6.3B-3.9B
 
 
 
 
 
Net Proceeds Stock Sale41.7M23.0M2.3B17.2M
 
 
 
 
 
Common Preferred Redeemed-639.2M-280.7M-55.6M0.00
 
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing26.5M12.5M24.2M17.1M
 
 
 
 
 
Other Uses - Financing210.9M741.3M197.7M158.4M
 
 
 
 
 
Net Cash Flow - Financing1.9B3.1B4.0B-2.4B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-10.3M3.8M-5.1M-29.0M
 
 
 
 
 
 
Net Change In Cash-219.9M748.2M-310.7M-248.7M